Physician profile
Alvin Ong
NPI 1992759138
$698,707.73
in general payments reported to CMS, 2019-2025
18 companies · $79K in 2025
The $79K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152K · 2020: $65K · 2021: $100K · 2022: $132K · 2023: $106K · 2024: $65K · 2025: $79K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $146K · Royalty Or License: $55K · Travel and Lodging: $40K · Food and Beverage: $6,484 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,075.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $145,825.00 |
| Royalty Or License | $55,047.80 |
| Travel and Lodging | $40,340.78 |
| Food and Beverage | $6,483.93 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,075.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $440,753.94 | 2019-2025 | Legion, Real Intelligence, Legion Revision |
| Stryker Corporation | $256,936.42 | 2019-2025 | Mako, Accolade, Trident |
| Depuy Synthes Sales INC. | $200.73 | 2019-2025 | Dynatape, Biocryl, Healix Knotless Peek |
| Zimmer Biomet Holdings, INC. | $173.53 | 2022-2025 | Persona, Gel-One Cross-Linked Hyaluronate |
| Pacira Pharmaceuticals Incorporated | $143.16 | 2022-2024 | Exparel |
| Becton, Dickinson and Company | $129.18 | 2022 | |
| Davol INC. | $51.53 | 2021 | |
| Globus Medical, INC. | $48.27 | 2023 | Distal Femur Plate System |
| Medacta USA, INC. | $45.94 | 2023 | Gmk Efficiency |
| Baxter Healthcare | $35.27 | 2023 | Floseal |
| Vertex Pharmaceuticals Incorporated | $32.99 | 2024-2025 | |
| Heraeus Medical, LLC. | $30.63 | 2024 | |
| Si-Bone, INC. | $29.52 | 2021 | |
| Ferring Pharmaceuticals INC. | $25.92 | 2019 | |
| Wright Medical Technology, INC. | $23.15 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $19.44 | 2025 | Hymovis |
| Next Science LLC | $15.43 | 2023 | Surgx, Xperience, Blastx |
| Horizon Therapeutics Plc | $12.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alvin Ong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.